Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ASA Spezialenzyme is a German biotechnology company founded in 1991 that specializes in the development, production, and distribution of high-activity enzymes, microbial mixed cultures, and other biotechnological products. The company serves a wide range of industries, including food and feed processing, organic synthesis, analytics, bioenergy, and paper/textiles. In the life sciences sector, ASA Spezialenzyme provides pharmaceutical enzymes, vaccine adjuvants (such as c-di-AMP), and contract research and manufacturing services. Notably, the company operates a state-of-the-art GMP cleanroom facility offering small-batch aseptic fill and finish services tailored for Phase I and II clinical trials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ASA Spezialenzyme.